168 related articles for article (PubMed ID: 31399787)
1. Baseline perfusion CT parameters as potential biomarkers in predicting long-term prognosis of localized clear cell renal cell carcinoma.
Wang Y; Cui L; Zhang J; Zhang L; Zhang J; Zhao X; Chen Y
Abdom Radiol (NY); 2019 Oct; 44(10):3370-3376. PubMed ID: 31399787
[TBL] [Abstract][Full Text] [Related]
2. Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers.
Reiner CS; Roessle M; Thiesler T; Eberli D; Klotz E; Frauenfelder T; Sulser T; Moch H; Alkadhi H
Invest Radiol; 2013 Apr; 48(4):183-91. PubMed ID: 23328912
[TBL] [Abstract][Full Text] [Related]
3. Perfusion CT in patients with metastatic renal cell carcinoma treated with interferon.
Ng CS; Wang X; Faria SC; Lin E; Charnsangavej C; Tannir NM
AJR Am J Roentgenol; 2010 Jan; 194(1):166-71. PubMed ID: 20028919
[TBL] [Abstract][Full Text] [Related]
4. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma.
Ding J; Xing Z; Jiang Z; Chen J; Pan L; Qiu J; Xing W
Eur J Radiol; 2018 Jun; 103():51-56. PubMed ID: 29803385
[TBL] [Abstract][Full Text] [Related]
5. Juxtatumoral perinephric fat analysis in clear cell renal cell carcinoma.
Gill TS; Varghese BA; Hwang DH; Cen SY; Aron M; Aron M; Duddalwar VA
Abdom Radiol (NY); 2019 Apr; 44(4):1470-1480. PubMed ID: 30506142
[TBL] [Abstract][Full Text] [Related]
6. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.
Nazari M; Shiri I; Hajianfar G; Oveisi N; Abdollahi H; Deevband MR; Oveisi M; Zaidi H
Radiol Med; 2020 Aug; 125(8):754-762. PubMed ID: 32193870
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis of renal cell carcinoma: perfusion CT findings.
Chen Y; Zhang J; Dai J; Feng X; Lu H; Zhou C
Abdom Imaging; 2010 Oct; 35(5):622-8. PubMed ID: 19763683
[TBL] [Abstract][Full Text] [Related]
9. High perirenal fat thickness predicts a poor progression-free survival in patients with localized clear cell renal cell carcinoma.
Huang H; Chen S; Li W; Wu X; Xing J
Urol Oncol; 2018 Apr; 36(4):157.e1-157.e6. PubMed ID: 29307598
[TBL] [Abstract][Full Text] [Related]
10. CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinib.
Haider MA; Vosough A; Khalvati F; Kiss A; Ganeshan B; Bjarnason GA
Cancer Imaging; 2017 Jan; 17(1):4. PubMed ID: 28114978
[TBL] [Abstract][Full Text] [Related]
11. Correlation between CT perfusion parameters and Fuhrman grade in pTlb renal cell carcinoma.
Chen C; Kang Q; Wei Q; Xu B; Ye H; Wang T; Lu Y; Lu J
Abdom Radiol (NY); 2017 May; 42(5):1464-1471. PubMed ID: 27999886
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic renal cell carcinoma: preliminary results from the Danish Renal Cancer Group Study-1.
Mains JR; Donskov F; Pedersen EM; Madsen HH; Rasmussen F
Invest Radiol; 2014 Sep; 49(9):601-7. PubMed ID: 24691140
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma: predicting RUNX3 methylation level and its consequences on survival with CT features.
Cen D; Xu L; Zhang S; Chen Z; Huang Y; Li Z; Liang B
Eur Radiol; 2019 Oct; 29(10):5415-5422. PubMed ID: 30877466
[TBL] [Abstract][Full Text] [Related]
14. Tumor Enhancement on Dynamic CT: A Predictive Factor for Recurrence After Nephrectomy in Localized T1 Clear Cell Renal Cell Carcinoma.
Maehara J; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Sugimoto M; Inokuchi J; Honda H
Anticancer Res; 2018 Apr; 38(4):2377-2383. PubMed ID: 29599364
[TBL] [Abstract][Full Text] [Related]
15. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
[TBL] [Abstract][Full Text] [Related]
16. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
[TBL] [Abstract][Full Text] [Related]
17. Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions.
Deniffel D; McAlpine K; Harder FN; Jain R; Lawson KA; Healy GM; Hui S; Zhang X; Salinas-Miranda E; van der Kwast T; Finelli A; Haider MA
Eur Radiol; 2023 Aug; 33(8):5840-5850. PubMed ID: 37074425
[TBL] [Abstract][Full Text] [Related]
18. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
[TBL] [Abstract][Full Text] [Related]
19. Utility of Pelvic CT for Surveillance of T2-T4 Renal Cell Carcinoma After Nephrectomy With Curative Intent.
Kaiser A; Davenport MS; Hafez KS; Alva A; Bailey JJ; Francis IR
AJR Am J Roentgenol; 2018 May; 210(5):1088-1091. PubMed ID: 29489406
[TBL] [Abstract][Full Text] [Related]
20. Small (<4 cm) clear cell renal cell carcinoma: correlation between CT findings and histologic grade.
Choi SY; Sung DJ; Yang KS; Kim KA; Yeom SK; Sim KC; Han NY; Park BJ; Kim MJ; Cho SB; Lee JH
Abdom Radiol (NY); 2016 Jun; 41(6):1160-9. PubMed ID: 27040407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
